PCVX: Vaxcyte Inc. Stocks News on April 1, 2025

Moderna, biotech stocks slide on resignation of FDA official Peter Marks

PCVX

Yahoo Finance

a day ago

Moderna, biotech stocks slide on resignation of FDA official Peter Marks

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

PCVX

Investor's Business Daily

a day ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

PCVX

MT Newswires

a day ago

Top Premarket Decliners

PCVX

MT Newswires

a day ago

Vaxcyte's Pneumococcal Conjugate Vaccine Candidate Shows Substantial Immune Response in Infants

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

PCVX

GlobeNewswire

a day ago

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

PCVX

Insider Monkey

2 days ago

Vaxcyte, Inc. (PCVX): One of the Best Debt Free Mid Cap Stocks to Buy Now

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

PCVX

GlobeNewswire

2 days ago

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

PCVX

Insider Monkey

2 days ago

Why Vaxcyte, Inc. (PCVX) Is Among the Best Mid Cap Biotech Stocks to Buy

PCVX

Insider Monkey

5 days ago

Is Vaxcyte, Inc. (PCVX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

PCVX

Insider Monkey

7 days ago

Vaxcyte (PCVX) Struggled Amid Political Uncertainty

PCVX

MT Newswires

25 days ago

Vaxcyte Insider Sold Shares Worth $353,699, According to a Recent SEC Filing

Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now

PCVX

TipRanks

25 days ago

Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now

PCVX

Insider Monkey

a month ago

Vaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy Now

PCVX

Insider Monkey

a month ago

Why Vaxcyte, Inc. (PCVX) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds

PCVX

Thomson Reuters StreetEvents

a month ago

Q4 2024 Vaxcyte Inc Earnings Call

PCVX

GuruFocus.com

a month ago

Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Financial Health and Promising ...

PCVX

MT Newswires

a month ago

Vaxcyte 2024 Loss Narrows

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

a month ago

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PCVX

Insider Monkey

a month ago

Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care

PCVX

Investor's Business Daily

2 months ago

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

PCVX

GlobeNewswire

2 months ago

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

PCVX

Investor's Business Daily

2 months ago

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

PCVX

Insider Monkey

2 months ago

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts

PCVX

MT Newswires

2 months ago

Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

PCVX

TipRanks

2 months ago

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants

PCVX

Clinical Trials Arena

2 months ago

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants

PCVX

MT Newswires

2 months ago

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

GlobeNewswire

2 months ago

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

PCVX

Zacks

2 months ago

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

PCVX

GlobeNewswire

2 months ago

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

PCVX

Insider Monkey

2 months ago

Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?

PCVX

MT Newswires

3 months ago

Vaxcyte Insider Sold Shares Worth $427,923, According to a Recent SEC Filing

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

PCVX

Zacks

3 months ago

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

PCVX

Insider Monkey

3 months ago

Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?

PCVX

MT Newswires

3 months ago

Vaxcyte Insider Sold Shares Worth $710,249, According to a Recent SEC Filing

PCVX

Insider Monkey

4 months ago

What Makes Vaxcyte (PCVX) An Investment Bet?

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants

PCVX

Clinical Trials Arena

4 months ago

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

GlobeNewswire

4 months ago

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

Insider Monkey

4 months ago

Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug

PCVX

MT Newswires

4 months ago

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

PCVX

GlobeNewswire

5 months ago

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

PCVX

Simply Wall St.

5 months ago

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

PCVX

GuruFocus.com

5 months ago

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

5 months ago

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

PCVX

Insider Monkey

5 months ago

Should You Consider Investing in Vaxcyte (PCVX)?

PCVX

MT Newswires

5 months ago

Vaxcyte Insider Sold Shares Worth $4,846,508, According to a Recent SEC Filing

PCVX

MT Newswires

6 months ago

Vaxcyte Insider Sold Shares Worth $6,283,861, According to a Recent SEC Filing

PCVX

MT Newswires

6 months ago

Vaxcyte Insider Sold Shares Worth $927,551, According to SEC Filing

PCVX

MT Newswires

6 months ago

Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

PCVX

Insider Monkey

7 months ago

Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

PCVX

GlobeNewswire

7 months ago

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

PCVX

MT Newswires

7 months ago

Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating

PCVX

MT Newswires

7 months ago

Vaxcyte Closes $1.5 Billion Offering of Shares, Warrants

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

PCVX

GlobeNewswire

7 months ago

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise

PCVX

BioPharma Dive

7 months ago

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise

PCVX

MT Newswires

7 months ago

Vaxcyte Prices $1.3 Billion Offering of Shares, Warrants

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

PCVX

GlobeNewswire

7 months ago

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results

PCVX

Zacks

7 months ago

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results

PCVX

Zacks

7 months ago

Company News for Sep 4, 2024

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales

PCVX

Bloomberg

7 months ago

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales

PCVX

MT Newswires

7 months ago

Vaxcyte Starts $1 Billion Underwritten Public Offering

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market

PCVX

Investor's Business Daily

7 months ago

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

PCVX

GlobeNewswire

7 months ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

PCVX

MT Newswires

7 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

PCVX

MT Newswires

7 months ago

Sector Update: Health Care Stocks Retreat in Afternoon Trading

PCVX

MT Newswires

7 months ago

Sector Update: Health Care

Heard on the Street: Pfizer Better Watch Out for This Biotech

PCVX

The Wall Street Journal

7 months ago

Heard on the Street: Pfizer Better Watch Out for This Biotech

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

PCVX

Benzinga

7 months ago

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market

PCVX

Investor's Business Daily

7 months ago

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market

PCVX

MT Newswires

7 months ago

Sector Update: Health Care

PCVX

MT Newswires

7 months ago

Vaxcyte Plans Phase 3 Trial for 31-Valent Pneumococcal Conjugate Vaccine Candidate After 'Positive' Phase 1/2 Study Results

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

GlobeNewswire

7 months ago

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

GlobeNewswire

7 months ago

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

MT Newswires

7 months ago

Vaxcyte Insider Sold Shares Worth $1,184,767, According to a Recent SEC Filing

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

8 months ago

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

PCVX

GuruFocus.com

8 months ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

PCVX

Zacks

8 months ago

Wall Street Analysts See a 25.16% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?

PCVX

Zacks

8 months ago

Are You Looking for a Top Momentum Pick? Why Vaxcyte, Inc. (PCVX) is a Great Choice

PCVX

MT Newswires

8 months ago

Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing

PCVX

MT Newswires

8 months ago

Vaxcyte Insider Sold Shares Worth $649,325, According to a Recent SEC Filing

PCVX

MT Newswires

8 months ago

Vaxcyte Insider Sold Shares Worth $425,000, According to a Recent SEC Filing

PCVX

GuruFocus.com

9 months ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

Vaxcyte Appoints John Furey to Board of Directors

PCVX

GlobeNewswire

9 months ago

Vaxcyte Appoints John Furey to Board of Directors

PCVX

MT Newswires

10 months ago

Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing

PCVX

Simply Wall St.

10 months ago

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

PCVX

GuruFocus.com

a year ago

Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

a year ago

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares

PCVX

GuruFocus.com

a year ago

Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

PCVX

GlobeNewswire

a year ago

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances

PCVX

GuruFocus.com

a year ago

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances

PCVX

GuruFocus.com

a year ago

Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares

30 Biggest Biotechnology Companies in the World

PCVX

Insider Monkey

a year ago

30 Biggest Biotechnology Companies in the World

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

PCVX

GlobeNewswire

a year ago

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

PCVX

Thomson Reuters StreetEvents

a year ago

Q4 2023 Vaxcyte Inc Earnings Call

PCVX

Zacks

a year ago

Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know

PCVX

Insider Monkey

a year ago

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

PCVX

Insider Monkey

a year ago

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

PCVX

GlobeNewswire

a year ago

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

PCVX

Zacks

a year ago

Latest Vaxcyte Inc. (PCVX) News on April 1, 2025

Share on Social Networks: